Taxotere's Psychological Side Effects

Women who permanently lose their hair as a result of Taxotere chemotherapy report devastating psychological side effects

Tuesday, March 13, 2018 - Not all side effects from anti-cancer chemotherapy are physical. Permanent hair loss can result in women experiencing life-changing emotional scarring. Taxotere permanent hair loss completely changes a woman's appearance and can make them look like they are permanently ill. Taxotere total body hair loss includes head hair, eyebrow and eyelash hair, arm, leg and all genital hair and is permanent and irreversible. Women generally accept a temporary loss of hair as a small price to pay to control their cancer and extend their life, but permanent hair loss is another story indeed. Many Taxotere permanent hair loss victims say that had they known that the treatment would cause permanent hair loss that they would have either chosen another drug or forgone chemotherapy altogether. Women claim that even the low rate of 10-15% chance of permanent hair loss is too high. Knowing that your hair would eventually grow back and that their disease would subside were the main reasons a woman would subject herself to the distress, embarrassment and public humiliation of being bald. Women cancer patients held out hope that once their chemotherapy treatments were over that their hair would grow back even thicker and more beautiful than before. One can imagine the anguish a woman feels when the realization that their hair is never coming back sinks in.

Because of the allegedly deceptive marketing practices of Sanofi sales representatives, thousands of Taxotere patient are suing and hiring the taxotere attorneys and experts due to their suffering from permanent, not temporary hair loss and many are suing Sanofi-Aventis claiming that the company failed to warn them. Plaintiffs cite that Canadians were warned by Sanofi as early as 2005 that Taxotere was linked to permanent hair loss in around 10% of patients. The warnings were tempered by stating that hair loss was common and, "reversible in most cases." Plaintiff's claims are bolstered by the fact that the makers of Taxotere, Sanofi-Aventis was proven to have made false and misleading statements by the Food and Drug Administration when they claimed that the drug was more effective at treating cancer than the alternatives already on the market such as Taxol.

Even today, any warning of permanent hair loss is tempered by the content of the Taxotere.com home page with the wording: "hair loss: in most cases, normal hair growth should return. In some cases (frequency not known) permanent hair loss has been observed." Cancer oncologists are urged to advise their clients of the Alopecia risks of Taxotere with the wording: "Explain to patients that side effects such as nausea, vomiting, diarrhea, constipation, fatigue, excessive tearing, infusion site reactions, and hair loss (cases of permanent hair loss have been reported) are associated with docetaxel administration."

Such ambiguity is little comfort to the thousands of women who now face having to go through the rest of their life without hair and deal with a lifetime of permanent disfigurement, depression and poor self-esteem and body image.

More Recent Taxotere Hair Loss Lawsuit News:

• Taxotere Alopecia Warning Limited to the Fine Print | 5/17/2019
• Women that have to undergo chemotherapy for the first time face great anxiety | 5/6/2019
• Taxotere Patients Denied Their Right To Make An Informed Decision | 4/24/2019
• Patients Must Be Made Aware Of Taxotere's Three Major Side Effects | 4/18/2019
• Women Are Angry Over Sanofi Failing To Warn About The Possibility of Permanent Hair Loss | 4/12/2019
• Women Undergoing Cancer Treatments Are Taking Better Care of Themselves to Limit Hair Loss | 4/5/2019
• Taxotere Permanent Hair Loss Has Devastating Psychological Implications For Patients | 3/25/2019
• Taxotere Causes Alopecia Which Can Be Psychologically Damaging | 3/20/2019
• Drug Makers Need To Write Clearer, More Descriptive Drug Warnings Starting With Taxotere | 3/18/2019
• Taxotere Lawsuits May Teach Doctors a Valuable Lesson | 3/13/2019
• Taxotere Permanent Baldness Warning | 4/30/2018
• Taxotere Chemotherapy and Permanent Hair Loss | 4/26/2018
• Sanofi Sales Representatives Oversold Taxotere | 4/24/2018
• Scientific Study Confirms Permanent Taxotere Hair Loss | 4/12/2018
• Chemotherapy Drug Side Effects | 4/9/2018
• Cancer Doctors Fail to Warn Patients | 4/4/2018
• Permanent Hair Loss Can Lead to Depression | 3/6/2018
• A Woman's Hair is Linked to Their Feminity | 2/23/2018
• Studies Indicate Taxotere Causes Permanent Hair Loss | 2/14/2018
• Taxotere's Ambiguous Hair Loss Warning | 2/5/2018
• Permanent Hair Loss Makes the Fear of Growing Old All Too Real | 12/29/2017
• Thousands of Women File Taxotere Hair Loss Lawsuits | 12/27/2017
• Taxotere Patients Psychological Trauma Result in Lawsuits Against Sanofi-Aventis | 12/22/2017
• Scientific Studies Point to Taxotere Hair Loss | 12/18/2017
• Cancer Patients Right to Make an Informed Decision | 12/13/2017
• How Women Think About Chemotherapy Hair Loss | 12/11/2017
• The Emotional Side Effects of Alopecia | 12/8/2017
• Taxotere May Cause Permanent Hair Loss | 12/4/2017
• Women Equate Baldness With Masculinity | 11/27/2017
• Symptoms of Permanent Hair Loss | 11/21/2017
• Taxotere's Warning May Have Come Too Late For Many | 11/15/2017
• Taxotere Benefits and Side Effects | 11/9/2017
• Women Were Not Given a Choice of Cancer Drugs | 11/1/2017
• The Impact of Permanent Hair Loss on Some Cancer Survivors | 9/29/2017
• The Emotional Side Effects of Permanent Hair Loss For Women Are All Too Real | 9/22/2017
• Taxotere is Highly Toxic and Causes Permanent Hair Loss | 9/15/2017
• 10-15 Percent of Cancer Patients Given Taxotere Develop Permanent Hair Loss | 9/8/2017
• Permanent Hair Loss From Taxotere is a Real Possibility | 9/1/2017
• Taxotere Permanent Hair Loss Lawsuits | 7/21/2017
• Permanent Hair Loss Caused by Taxotere | 6/26/2017
• Taxotere Warnings Now Include Permanent Hair Loss | 6/19/2017
• Taxotere Hair Loss Lawsuits Focus on Warning Label | 6/12/2017
• Permanent Hair Loss in Some Taxotere Users Delivers Secondary Blow to Cancer Patients | 6/5/2017

Lawyers for Taxotere Hair Loss Lawsuits

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.